MapLight Therapeutics, Inc.
MPLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $759,806 | $759,806 | $759,806 |
| - Cash | $38,253 | $79,769 | $27,665 |
| + Debt | $6,579 | $5,924 | $6,271 |
| Enterprise Value | $728,132 | $685,961 | $738,412 |
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Gross Profit | -$701 | -$556 | -$574 |
| % Margin | – | – | – |
| EBITDA | -$76,879 | -$55,153 | -$29,442 |
| % Margin | – | – | – |
| Net Income | -$77,580 | -$55,709 | -$30,016 |
| % Margin | – | – | – |
| EPS Diluted | -1.87 | -1.34 | -0.72 |
| % Growth | -39.6% | -86.1% | – |
| Operating Cash Flow | -$78,815 | -$52,006 | -$26,577 |
| Capital Expenditures | -$770 | -$462 | -$746 |
| Free Cash Flow | -$79,585 | -$52,468 | -$27,323 |